Search results
Results from the WOW.Com Content Network
Pneumococcal vaccine. 23-valent pneumococcal polysaccharide vaccine by MSD as it is marketed in Japan. Pneumococcal vaccines are vaccines against the bacterium Streptococcus pneumoniae. [1] Their use can prevent some cases of pneumonia, meningitis, and sepsis. [1] There are two types of pneumococcal vaccines: conjugate vaccines and ...
Pulmonology. Pneumococcal pneumonia is a type of bacterial pneumonia that is caused by Streptococcus pneumoniae (pneumococcus). [1] It is the most common bacterial pneumonia found in adults, the most common type of community-acquired pneumonia, and one of the common types of pneumococcal infection. The estimated number of Americans with ...
Four million per year [ 12 ][ 13 ] Pneumonia is an inflammatory condition of the lung primarily affecting the small air sacs known as alveoli. [ 3 ][ 14 ] Symptoms typically include some combination of productive or dry cough, chest pain, fever, and difficulty breathing. [ 15 ] The severity of the condition is variable.
Merck's vaccine, branded Capvaxive, helped produce an immune response against all 21 serotypes, or variations of the bacteria, that the shot targeted in a variety of adult populations across studies.
Classification of pneumonia. Pneumonia can be classified in several ways, most commonly by where it was acquired (hospital versus community), but may also by the area of lung affected or by the causative organism. [1] There is also a combined clinical classification, which combines factors such as age, risk factors for certain microorganisms ...
Pneumococcal infection is an infection caused by the bacterium Streptococcus pneumoniae. [1] S. pneumoniae is a common member of the bacterial flora colonizing the nose and throat of 5–10% of healthy adults and 20–40% of healthy children. [2] However, it is also a cause of significant disease, being a leading cause of pneumonia, bacterial ...
Prevnar vaccine. Prevnar 20 (PCV20) is the third version of a vaccine produced by the Wyeth subsidiary of Pfizer.In April 2023, the FDA approved Prevnar 20 for the prevention of invasive disease caused by the 20 different serotypes of S. pneumoniae contained in the vaccine (serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F) for individuals 6 ...
Pneumococcal polysaccharide vaccine, sold under the brand name Pneumovax 23, is a pneumococcal vaccine that is used for the prevention of pneumococcal disease caused by the 23 serotypes of Streptococcus pneumoniae contained in the vaccine as capsular polysaccharides. [2] It is given by intramuscular or subcutaneous injection.